ezogabine has been researched along with Sclerosis in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Citraro, R; Coppola, A; De Sarro, G; Del Gaudio, L; Palleria, C; Russo, E; Striano, S | 1 |
Brandt, C; Ebert, U; Löscher, W | 1 |
1 review(s) available for ezogabine and Sclerosis
Article | Year |
---|---|
Perspectives on treatment options for mesial temporal lobe epilepsy with hippocampal sclerosis.
Topics: Acetamides; Anticonvulsants; Carbamates; Clinical Trials as Topic; Dibenzazepines; Epilepsy, Temporal Lobe; Hippocampus; Humans; Lacosamide; Levetiracetam; Nitriles; Phenylenediamines; Piracetam; Pyridones; Sclerosis; Syndrome | 2015 |
1 other study(ies) available for ezogabine and Sclerosis
Article | Year |
---|---|
Delayed sclerosis, neuroprotection, and limbic epileptogenesis after status epilepticus in the rat.
Topics: Animals; Anticonvulsants; Apoptosis; Biomarkers; Carbamates; Caspase Inhibitors; Dizocilpine Maleate; Enzyme Inhibitors; Epilepsy; Female; Hippocampus; Limbic System; Neuroprotective Agents; Phenylenediamines; Rats; Rats, Wistar; Sclerosis; Status Epilepticus; Time Factors | 2002 |